Home › IGA Glomerulonephritis › California › Los Angeles
IGA Glomerulonephritis clinical trials in Los Angeles, CA
4 studies for IGA Glomerulonephritis are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
RecruitingPhase 3
- UCLA Health David Geffen School of Medicine, Los Angeles
Study of WAL0921 in Patients With Glomerular Kidney Diseases
RecruitingPhase 2
- Academic Medical Research Institute, Los Angeles
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
RecruitingPhase 2
- UCLA Medical Center, Los Angeles
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- Cedars-Sinai Medical Center, Los Angeles
IGA Glomerulonephritis trials in other cities
- Houston, TX9 studies
- Denver, CO5 studies
- Orlando, FL5 studies
- Sioux City, IA4 studies
- Boston, MA3 studies
- New York City, NY3 studies
- Johns Creek, GA3 studies
- Philadelphia, PA3 studies
- Columbus, OH3 studies
- Cedar Rapids, IA3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer72 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.